4//SEC Filing
Ridge Valley Corp 4
Accession 0001213900-19-006996
CIK 0001218683other
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 8:00 PM ET
Size
8.0 KB
Accession
0001213900-19-006996
Insider Transaction Report
Form 4
Ridge Valley Corp
10% Owner
Transactions
- Sale
Investment Rights
2019-04-21−94,382→ 0 totalExercise: $1.33From: 2019-04-21Exp: 2019-11-30→ Common Stock (94,382 underlying) - Sale
Convertible Loans
2019-04-21−265,531→ 0 totalExercise: $1.11Exp: 2019-05-31→ Common Stock (265,531 underlying)
Footnotes (2)
- [F1]Issuable upon the conversion of the convertible loans under the January 19, 2017 Loan Agreement (the "Loan Agreement") by and among the Issuer and Ridge Valley Corporation, among others. The Convertible Loans may be converted at any time.
- [F2]The purchaser waived a debt owed to him by Ridge Valley Corporation as consideration for these derivative securities.
Documents
Issuer
Wize Pharma, Inc.
CIK 0001218683
Entity typeother
IncorporatedSeychelles
Related Parties
1- filerCIK 0001722230
Filing Metadata
- Form type
- 4
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 8:00 PM ET
- Size
- 8.0 KB